牙周病在非酒精性脂肪性肝病中的作用及机制研究进展

doi:10.16138/j.1673-6087.2023.02.009

摘要/Abstract

关键词: 非酒精性脂肪性肝病, 牙龈卟啉单胞菌, 牙周病, 肠道菌群紊乱, 内毒素血症, 巨噬细胞极化, 氧化应激, 昼夜紊乱

中图分类号:

R575.5

段中华, 王宇华, 郭斯敏. 牙周病在非酒精性脂肪性肝病中的作用及机制研究进展[J]. 内科理论与实践, 2023, 18(02): 107-110.

DUAN Zhonghua, WANG Yuhua, GUO Simin. Advances in research on effect of periodontitis on non-alcoholic fatty liver disease and mechanism[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 107-110.

参考文献 29

[1]	Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84. doi: 10.1002/hep.28431 pmid: 26707365
[2]	Younossi ZM, Otgonsuren M, Henry L, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009[J]. Hepatology, 2015, 62(6): 1723-1730. doi: 10.1002/hep.28123 pmid: 26274335
[3]	Holt SC, Ebersole JL. Porphyromonas gingivalis, treponema denticola, and tannerella forsythia: the“red complex”, a prototype polybacterial pathogenic consortium in periodontitis[J]. Periodontol, 2005, 38: 72-122. doi: 10.1111/prd.2005.38.issue-1 URL
[4]	Furuta M, Ekuni D, Yamamoto T, et al. Relationship between periodontitis and hepatic abnormalities in young adults[J]. Acta Odontologica Scandinavica, 2010, 68(1): 27-33. doi: 10.3109/00016350903291913 pmid: 19878045
[5]	Kim JY, Lee GN, Song HC, et al. Association between fatty liver index and periodontitis: the Korea National Health and Nutrition Examination Survey[J]. Sci Rep, 2020, 10(1): 3805. doi: 10.1038/s41598-020-60797-7
[6]	Kuroe K, Furuta M, Takeuchi K, et al. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults[J]. J Clin Periodontol, 2021, 48(3): 368-377. doi: 10.1111/jcpe.13415 pmid: 33368494
[7]	Akinkugbe AA, Slade GD, Barritt AS, et al. Periodontitis and non-alcoholic fatty liver disease, a population-based cohort investigation in the Study of Health in Pomerania[J]. J Clin Periodontol, 2017, 44(11): 1077-1087. doi: 10.1111/jcpe.12800 pmid: 28804947
[8]	杜芹, 马歆茹. 牙周致病菌与系统性疾病的相关性研究进展[J]. 南方医科大学学报, 2020, 40(5): 759-764.
[9]	Yoneda M, Naka S, Nakano K, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease[J]. BMC Gastroenterol, 2012, 12: 16. doi: 10.1186/1471-230X-12-16 URL
[10]	Nakahara T, Hyogo H, Ono A, et al. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease[J]. J Gastroenterol, 2018, 53(2): 269-280. doi: 10.1007/s00535-017-1368-4 pmid: 28741270
[11]	Furusho H, Miyauchi M, Hyogo H, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice[J]. J Gastroenterol, 2013, 48(11): 1259-1270. doi: 10.1007/s00535-012-0738-1 pmid: 23307045
[12]	Kuraji R, Ito H, Fujita M, et al. Porphyromonas gingivalis induced periodontitis exacerbates progression of non-alcoholic steatohepatitis in rats[J]. Clin Exp Dent Res, 2016, 2(3): 216-225. doi: 10.1002/cre2.v2.3 URL
[13]	杜留熠, 孙晓琳, 于维先, 等. 牙龈卟啉单胞菌菌毛致病机制的研究进展[J]. 中华口腔医学杂志, 2018, 53(10): 703-707.
[14]	Nakano K, Inaba H, Nomura R, et al. Distribution of Porphyromonas gingivalis fimA genotypes in cardiovascular specimens from Japanese patients[J]. Oral Microbiol Immunol, 2008, 23(2): 170-172. doi: 10.1111/omi.2008.23.issue-2 URL
[15]	Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota[J]. Sci Rep, 2014, 4: 4828. doi: 10.1038/srep04828 pmid: 24797416
[16]	Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver[J]. PLoS One, 2015, 10(7): e0134234. doi: 10.1371/journal.pone.0134234 URL
[17]	Yamazaki K, Kato T, Tsuboi Y, et al. Oral pathobiont-induced changes in gut microbiota aggravate the pathology of nonalcoholic fatty liver disease in mice[J]. Front Immunol, 2021, 12: 766170. doi: 10.3389/fimmu.2021.766170 URL
[18]	Armingohar Z, Jørgensen JJ, Kristoffersen AK, et al. Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis[J]. J Oral Microbiol, 2014, 6(1): 3402.
[19]	Geerts SO, Nys M, De MP, et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity[J]. J Periodontol, 2002, 73(1): 73-78. doi: 10.1902/jop.2002.73.1.73 pmid: 11846202
[20]	Wahaidi VY, Kowolik MJ, Eckert GJ, et al. Endotoxemia and the host systemic response during experimental gingivitis[J]. J Clin Periodontol, 2011, 38(5): 412-417. doi: 10.1111/j.1600-051X.2011.01710.x pmid: 21320151
[21]	Sasaki N, Katagiri S, Komazaki R, et al. Endotoxemia by porphyromonas gingivalis injection aggravates non-alcoholic fatty liver disease, disrupts glucose/lipid metabolism, and alters gut microbiota in mice[J]. Front Microbiol, 2018, 9: 2470. doi: 10.3389/fmicb.2018.02470 pmid: 30405551
[22]	张冬霞, 林江. 中性粒细胞在牙周炎和糖尿病双向关系中作用的研究进展[J]. 医学综述, 2019, 25(17): 3338-3343.
[23]	邹慧琼, 刘雅芳, 周家敏, 等. 牙周非手术治疗对慢性牙周炎患者循环CD34⁺/CD309⁺/CD45^-内皮祖细胞和氧化三甲胺的影响[J]. 临床口腔医学杂志, 2022, 38(2): 82-86.
[24]	Méndez-Sánchez N, Valencia-Rodríguez A, Coronel-Castillo C, et al. The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis[J]. Ann Transl Med, 2020, 8(6): 400. doi: 10.21037/atm.2020.02.184 pmid: 32355844
[25]	Yu S, Ding L, Liang D, et al. Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice[J]. Mol Oral Microbiol, 2018, 33(5): 388-395. doi: 10.1111/omi.12241 pmid: 30007055
[26]	周玲. 牙龈卟啉单胞菌脂多糖对骨质疏松大鼠骨髓巨噬细胞生物学行为的影响[D]. 福州: 福建医科大学, 2019.
[27]	Han YH, Kim HJ, Na H, et al. RORα induces KLF4-mediated M2 polarization in the liver macrophages that protect against nonalcoholic steatohepatitis[J]. Cell Reports, 2017, 20(1):124-135. doi: 10.1016/j.celrep.2017.06.017 URL
[28]	Neufeld-Cohen A, Robles MS, Aviram R, et al. Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins[J]. Proc Natl Acad Sci U S A, 2016, 113(12): E1673-E1682.
[29]	Gooley JJ. Circadian regulation of lipid metabolism[J]. Proc Nutr Soc, 2016, 75(4): 440-450. pmid: 27225642

牙周病在非酒精性脂肪性肝病中的作用及机制研究进展

Advances in research on effect of periodontitis on non-alcoholic fatty liver disease and mechanism

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 29

相关文章 15

编辑推荐

Metrics

本文评价

[1]	尚思雨, 相阳, 潘博涵. 褐藻寡糖对创面的生物学效应：裂解程度依赖性 [J]. 组织工程与重建外科杂志, 2023, 19(1): 1-.
[2]	周荣　综述　高伟成　审校. 老年性上睑下垂发生机制研究进展[J]. 组织工程与重建外科杂志, 2022, 18(3): 281-.
[3]	秦雪, 郭华, 张云云, 崔小川. C1q肿瘤坏死因子相关蛋白3与代谢相关疾病的研究进展[J]. 内科理论与实践, 2022, 17(06): 482-485.
[4]	刘洋徐慧刘蔡钺杨雅骊. 氢分子医学在皮肤美容的应用进展 [J]. 组织工程与重建外科杂志, 2021, 17(3): 278-.
[5]	罗丹阳, 高益鸣. 口腔菌群与胰腺癌的相关性研究进展[J]. 外科理论与实践, 2021, 26(01): 84-86.
[6]	李少博, 杨迪, 韩峻峰. 身体成分变化与非酒精性脂肪性肝病的相关研究进展[J]. 诊断学理论与实践, 2021, 20(01): 104-108.
[7]	刘冰滢, 王文波, 黄佳, 高振, 武晓莉, 刘伟. 积雪草酸葡糖胺盐凝胶通过调节巨噬细胞迁移和极化促进创面愈合及表皮再生[J]. 组织工程与重建外科杂志, 2020, 16(2): 112-118.
[8]	石云, 方云芬, 代华杰, 陈晓鸥, 谭利民, 汤明明, 唐志军, 朱雯, 邓婵娟, 禤立平, 王天歌, 徐敏, 毕宇芳, 王卫庆, 张寅飞,. 尿液pH值和非酒精性脂肪性肝病的相关性研究[J]. 内科理论与实践, 2019, 14(06): 337-341.
[9]	朱雯, 邓婵娟, 代华杰, 禤立平, 李勉, 陈宇红, 张寅飞, 王卫庆, 毕宇芳, 徐敏, 郑昇,. 胰岛素抵抗指数与非酒精性脂肪性肝病肝纤维化进展程度的相关性研究[J]. 内科理论与实践, 2019, 14(06): 342-348.
[10]	陈超波, 蒋兆彦. 胆汁酸代谢与非酒精性脂肪性肝病[J]. 外科理论与实践, 2019, 24(04): 371-374.
[11]	朱红灿, 高萌, 张新凯,. 急性一氧化碳中毒迟发性脑病发病机制的研究进展[J]. 内科理论与实践, 2018, 13(05): 264-268.
[12]	邵文涛, 孙海东, 王起晗, 刘倩, 蒋兆彦, 顾爱华. 盐酸小檗碱缓解高胆固醇所致肝脏损伤的机制体外及动物实验研究[J]. 诊断学理论与实践, 2018, 17(03): 311-317.
[13]	肖永胜, 周俭. 非酒精性脂肪性肝病与肝细胞癌[J]. 外科理论与实践, 2018, 23(03): 210-213.
[14]	李小英, 焦阳,. 浅谈脂肪肝治疗[J]. 内科理论与实践, 2017, 12(04): 230-235.
[15]	朱翠玲, 钱春花, 张怡, 高晶扬, 尤慧, 卢列盛, 董恒生, 周东雷, 曲伸,. 代谢性手术治疗重度肥胖伴非酒精性脂肪性肝病患者的疗效观察[J]. 内科理论与实践, 2017, 12(04): 256-261.